Arthritis Rheum. 1977 Sep-Oct;20(7):1396-1401.

Zymosan-induced arthritis: a model of chronic proliferative arthritis following activation of the alternative pathway of complement.

Keystone EC, Schorlemmer HU, Pope C, Allison AC.

Abstract

Zymosan particles, which are able to activate complement by the alternative pathway and to induce enzyme secretion from macrophages, were injected into knee joints of mice. After various time intervals, synovia were assessed histologically for various markers of inflammation. Within 7 days after intraarticular injection of zymosan, a chronic inflammatory arthritis with mononuclear cell infiltration, synovial hypertrophy and pannus formation was observed. Latex particles, which do not activate complement or macrophages, produced only mild, transient inflammatory reactions.

PMID:: 911357; [PubMed - indexed for MEDLINE]

MeSH Terms, Substances

MeSH Terms

Substances

LinkOut - more resources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Libraries

LinkOut Holdings

Supplemental Content

Save items

Related citations in PubMed

Characterization of zymosan-induced arthritis in the rat: effects on joint inflammation and cartilage metabolism. [Life Sci. 1994]
Characterization of zymosan-induced arthritis in the rat: effects on joint inflammation and cartilage metabolism.
Gegout P, Gillet P, Chevrier D, Guingamp C, Terlain B, Netter P. Life Sci. 1994; 55(17):PL321-6.
Local activation of STAT-1 and STAT-3 in the inflamed synovium during zymosan-induced arthritis: exacerbation of joint inflammation in STAT-1 gene-knockout mice. [Arthritis Rheum. 2004]
Local activation of STAT-1 and STAT-3 in the inflamed synovium during zymosan-induced arthritis: exacerbation of joint inflammation in STAT-1 gene-knockout mice.
de Hooge AS, van de Loo FA, Koenders MI, Bennink MB, Arntz OJ, Kolbe T, van den Berg WB. Arthritis Rheum. 2004 Jun; 50(6):2014-23.
Reduced cartilage proteoglycan loss during zymosan-induced gonarthritis in NOS2-deficient mice and in anti-interleukin-1-treated wild-type mice with unabated joint inflammation. [Arthritis Rheum. 1998]
Reduced cartilage proteoglycan loss during zymosan-induced gonarthritis in NOS2-deficient mice and in anti-interleukin-1-treated wild-type mice with unabated joint inflammation.
van de Loo FA, Arntz OJ, van Enckevort FH, van Lent PL, van den Berg WB. Arthritis Rheum. 1998 Apr; 41(4):634-46.
Endothelins modulate inflammatory reaction in zymosan-induced arthritis: participation of LTB4, TNF-alpha, and CXCL-1. [J Leukoc Biol. 2008]
Endothelins modulate inflammatory reaction in zymosan-induced arthritis: participation of LTB4, TNF-alpha, and CXCL-1.
Conte Fde P, Barja-Fidalgo C, Verri WA Jr, Cunha FQ, Rae GA, Penido C, Henriques MG. J Leukoc Biol. 2008 Sep; 84(3):652-60. Epub 2008 May 30.
Review [Pathology and progression of intra-articular inflammation in rheumatoid arthritis]. [Verh Dtsch Ges Pathol. 1996]
Review [Pathology and progression of intra-articular inflammation in rheumatoid arthritis].
Geiler G. Verh Dtsch Ges Pathol. 1996; 80:46-57.

See reviews... See all...

Cited by 29 PubMed Central articles

Dectin-1 and NOD2 mediate cathepsin activation in zymosan-induced arthritis in mice. [Inflamm Res. 2011]
Dectin-1 and NOD2 mediate cathepsin activation in zymosan-induced arthritis in mice.
Rosenzweig HL, Clowers JS, Nunez G, Rosenbaum JT, Davey MP. Inflamm Res. 2011 Jul; 60(7):705-14. Epub 2011 Mar 20.
Experimental model of zymosan-induced arthritis in the rat temporomandibular joint: role of nitric oxide and neutrophils. [J Biomed Biotechnol. 2011]
Experimental model of zymosan-induced arthritis in the rat temporomandibular joint: role of nitric oxide and neutrophils.
Chaves HV, Ribeiro Rde A, de Souza AM, Rodrigues e Silva AA, Gomes AS, Vale ML, Bezerra MM, Brito GA. J Biomed Biotechnol. 2011; 2011:707985. Epub 2011 Jan 3.
Interleukin-18 as an in vivo mediator of monocyte recruitment in rodent models of rheumatoid arthritis. [Arthritis Res Ther. 2010]
Interleukin-18 as an in vivo mediator of monocyte recruitment in rodent models of rheumatoid arthritis.
Ruth JH, Park CC, Amin MA, Lesch C, Marotte H, Shahrara S, Koch AE. Arthritis Res Ther. 2010; 12(3):R118. Epub 2010 Jun 16.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Zymosan-induced arthritis: a model of chronic proliferative arthritis following ...
Zymosan-induced arthritis: a model of chronic proliferative arthritis following activation of the alternative pathway of complement.
Arthritis Rheum. 1977 Sep-Oct ;20(7):1396-1401.

PubMed
Polyenylphosphatidylcholine decreases alcohol-induced oxidative stress in the ba...
Polyenylphosphatidylcholine decreases alcohol-induced oxidative stress in the baboon.
Alcohol Clin Exp Res. 1997 Apr ;21(2):375-9.

PubMed
Pleuropulmonary manifestations of ankylosing spondylitis.
Pleuropulmonary manifestations of ankylosing spondylitis.
Mayo Clin Proc. 1977 Oct ;52(10):641-9.

PubMed
Removal of osteoclast bone resorption products by transcytosis.
Removal of osteoclast bone resorption products by transcytosis.
Science. 1997 Apr 11 ;276(5310):270-3.

PubMed
A comparison of three W170 protocols.
A comparison of three W170 protocols.
Eur J Appl Physiol Occup Physiol. 1977 Sep 16 ;37(2):123-8.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: